Skip to main content
Top
Published in: Psychiatric Quarterly 1/2016

01-03-2016 | Original Paper

The Formation of Marijuana Risk Perception in a Population of Substance Abusing Patients

Authors: Samuel T. Wilkinson, Gerrit I. van Schalkwyk, Larry Davidson, Deepak C. D’Souza

Published in: Psychiatric Quarterly | Issue 1/2016

Login to get access

Abstract

Risk perception has been shown to be protective with regard to marijuana use. Notably, the risk perception of marijuana in individuals with substance abuse problems varies significantly from that of the general public. Understanding how risk perception is formed in substance users could explain these differences and help predict the consequences of policy changes. Using this framework, we explored risk perception and its formation in a sample of substance abusing veterans. Semi-structured interviews were conducted with veterans who were receiving treatment for substance abuse. Interviews were recorded digitally, transcribed verbatim, and analyzed using inductive thematic analysis. A prominent perspective among the 31 participants was that marijuana is significantly different from other drugs because it is safe, not addictive, not associated with physical withdrawal, and has less overt behavioral effects than other substances. Many of these participants drew upon their own innocuous experiences with the drug in developing this perspective, more so than information from any other source. A contrasting narrative emphasized marijuana’s capacity to cause negative social consequences, act as a gateway to the use of other, more harmful substances, and cause paranoia or worsen psychosis. In conclusion, individual experience with marijuana featured more prominently in informing risk perception than any other source of information. Our results and previous literature suggest that the significant disconnect between the individual experiences of substance users and the current clinical and legal policy towards marijuana may weaken the legitimacy of public policy or the authority of the medical community.
Literature
1.
go back to reference Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2009 National Survey on Drug Use and Health, vol. I, Summary of National Findings. Rockville, Office of Applied Studies, 2010. Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2009 National Survey on Drug Use and Health, vol. I, Summary of National Findings. Rockville, Office of Applied Studies, 2010.
2.
go back to reference Ferner M, Mathias C. Here’s Why New York Needs to Legalize Medical Marijuana Now. New York, Huffington Post, 2014. Ferner M, Mathias C. Here’s Why New York Needs to Legalize Medical Marijuana Now. New York, Huffington Post, 2014.
3.
go back to reference Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. New England Journal of Medicine 370(23):2219–2227, 2014.CrossRefPubMed Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. New England Journal of Medicine 370(23):2219–2227, 2014.CrossRefPubMed
4.
go back to reference Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28(5):849–863, 2004.CrossRefPubMed Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28(5):849–863, 2004.CrossRefPubMed
5.
go back to reference Brook JS, Stimmel MA, Zhang C, Brook DW. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. American Journal on Addictions 17(2):155–160, 2008.PubMedCentralCrossRefPubMed Brook JS, Stimmel MA, Zhang C, Brook DW. The association between earlier marijuana use and subsequent academic achievement and health problems: a longitudinal study. American Journal on Addictions 17(2):155–160, 2008.PubMedCentralCrossRefPubMed
6.
go back to reference Brook JS, Adams RE, Balka EB, Johnson E. Early adolescent marijuana use: Risks for the transition to young adulthood. Psychological Medicine 32(1):79–91, 2002.CrossRefPubMed Brook JS, Adams RE, Balka EB, Johnson E. Early adolescent marijuana use: Risks for the transition to young adulthood. Psychological Medicine 32(1):79–91, 2002.CrossRefPubMed
7.
go back to reference Wilkinson ST, Radhakrishnan R, D’Souza DC. Impact of cannabis use on the development of psychotic disorders. Current Addiction Reports 1(2):115–128, 2014.PubMedCentralCrossRefPubMed Wilkinson ST, Radhakrishnan R, D’Souza DC. Impact of cannabis use on the development of psychotic disorders. Current Addiction Reports 1(2):115–128, 2014.PubMedCentralCrossRefPubMed
8.
go back to reference Danseco ER, Kingery PM, Coggeshall MB. Perceived risk of harm from marijuana use among youth in the USA. School Psychology International 20(1):39–56, 1999.CrossRef Danseco ER, Kingery PM, Coggeshall MB. Perceived risk of harm from marijuana use among youth in the USA. School Psychology International 20(1):39–56, 1999.CrossRef
9.
go back to reference Lopez-Quintero C, Neumark Y. Effects of risk perception of marijuana use on marijuana use and intentions to use among adolescents in Bogota, Colombia. Drug and Alcohol Dependence 109(1–3):65–72, 2010.CrossRefPubMed Lopez-Quintero C, Neumark Y. Effects of risk perception of marijuana use on marijuana use and intentions to use among adolescents in Bogota, Colombia. Drug and Alcohol Dependence 109(1–3):65–72, 2010.CrossRefPubMed
10.
go back to reference Duistman DM, Colbry SL. Perceived risk and use as predictors of substance use among college students. Health Values: The Journal of Health Behavior, Education and Promotion 19(2):44–52, 1995. Duistman DM, Colbry SL. Perceived risk and use as predictors of substance use among college students. Health Values: The Journal of Health Behavior, Education and Promotion 19(2):44–52, 1995.
11.
go back to reference Calabria B, Swift W, Slade T, Hall W, Copeland J. The perceived health risks of cannabis use in an Australian household survey. Drug and Alcohol Review 31(6):809–812, 2012.CrossRefPubMed Calabria B, Swift W, Slade T, Hall W, Copeland J. The perceived health risks of cannabis use in an Australian household survey. Drug and Alcohol Review 31(6):809–812, 2012.CrossRefPubMed
12.
go back to reference Darke S, Torok M. Attitudes of regular injecting drug users towards the legal status of the major illicit drugs. Drug and Alcohol Review 32(5):483–488, 2013.PubMed Darke S, Torok M. Attitudes of regular injecting drug users towards the legal status of the major illicit drugs. Drug and Alcohol Review 32(5):483–488, 2013.PubMed
13.
go back to reference Lancaster K, Ritter A, Stafford J. Public opinion and drug policy in Australia: Engaging the ‘affected community’. Drug and Alcohol Review 32(1):60–66, 2013.CrossRefPubMed Lancaster K, Ritter A, Stafford J. Public opinion and drug policy in Australia: Engaging the ‘affected community’. Drug and Alcohol Review 32(1):60–66, 2013.CrossRefPubMed
14.
go back to reference Kleber HD, DuPont RL. Physicians and medical marijuana. American Journal of Psychiatry 169(6):564–568, 2012.CrossRefPubMed Kleber HD, DuPont RL. Physicians and medical marijuana. American Journal of Psychiatry 169(6):564–568, 2012.CrossRefPubMed
15.
go back to reference Palamar JJ, Ompad DC, Petkova E. Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization. International Journal of Drug Policy 25(3):424–435, 2014.PubMedCentralCrossRefPubMed Palamar JJ, Ompad DC, Petkova E. Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization. International Journal of Drug Policy 25(3):424–435, 2014.PubMedCentralCrossRefPubMed
16.
go back to reference Choo EK, Benz M, Zaller N, Warren O, Rising KL, McConnell KJ. The impact of state medical marijuana legislation on adolescent marijuana use. Journal of Adolescent Health, 55:160–166, 2014.CrossRefPubMed Choo EK, Benz M, Zaller N, Warren O, Rising KL, McConnell KJ. The impact of state medical marijuana legislation on adolescent marijuana use. Journal of Adolescent Health, 55:160–166, 2014.CrossRefPubMed
17.
go back to reference Patton MQ. Qualitative Research and Evaluation Methods. Thousand Oaks, Sage Publications, 2002. Patton MQ. Qualitative Research and Evaluation Methods. Thousand Oaks, Sage Publications, 2002.
18.
go back to reference Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383–1391, 2009.CrossRefPubMed Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 374(9698):1383–1391, 2009.CrossRefPubMed
19.
go back to reference Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry 161(11):1967–1977, 2004.CrossRefPubMed Budney AJ, Hughes JR, Moore BA, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry 161(11):1967–1977, 2004.CrossRefPubMed
20.
go back to reference Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2(3):244, 1994.CrossRef Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Experimental and Clinical Psychopharmacology 2(3):244, 1994.CrossRef
21.
go back to reference Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. New York, The Guilford Press, 2013. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. New York, The Guilford Press, 2013.
22.
go back to reference Duff C, Asbridge M, Brochu S, Cousineau M-M, Hathaway AD, Marsh D, et al. A Canadian perspective on cannabis normalization among adults. Addiction Research and Theory 20(4):271–283, 2012.CrossRef Duff C, Asbridge M, Brochu S, Cousineau M-M, Hathaway AD, Marsh D, et al. A Canadian perspective on cannabis normalization among adults. Addiction Research and Theory 20(4):271–283, 2012.CrossRef
23.
go back to reference Temple EC, Brown RF, Hine DW. The ‘grass ceiling’: Limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction 106(2):238–244, 2011.CrossRefPubMed Temple EC, Brown RF, Hine DW. The ‘grass ceiling’: Limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction 106(2):238–244, 2011.CrossRefPubMed
24.
go back to reference Coomber R, Oliver M, Morris C. Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues 33(2):325–356, 2003.CrossRef Coomber R, Oliver M, Morris C. Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues 33(2):325–356, 2003.CrossRef
25.
go back to reference Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction 101(4):556–569, 2006.CrossRefPubMed Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction 101(4):556–569, 2006.CrossRefPubMed
26.
go back to reference Martin-Sanchez E, Furukawa TA, Taylor J, Martin JL. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine (Malden, Mass) 10(8):1353–1368, 2009.CrossRef Martin-Sanchez E, Furukawa TA, Taylor J, Martin JL. Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Medicine (Malden, Mass) 10(8):1353–1368, 2009.CrossRef
27.
go back to reference Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Tolerance to effects of high-dose oral delta9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. Journal of Analytical Toxicology 37(1):11–16, 2013.PubMedCentralCrossRefPubMed Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Tolerance to effects of high-dose oral delta9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. Journal of Analytical Toxicology 37(1):11–16, 2013.PubMedCentralCrossRefPubMed
28.
go back to reference Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) 214(2):391–401, 2011.CrossRef Ramaekers JG, Theunissen EL, de Brouwer M, Toennes SW, Moeller MR, Kauert G. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) 214(2):391–401, 2011.CrossRef
29.
go back to reference Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Current Opinion in Psychiatry 19(3):233–238, 2006.CrossRefPubMed Budney AJ, Hughes JR. The cannabis withdrawal syndrome. Current Opinion in Psychiatry 19(3):233–238, 2006.CrossRefPubMed
30.
go back to reference D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29(8):1558–1572, 2004.CrossRefPubMed D’Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29(8):1558–1572, 2004.CrossRefPubMed
Metadata
Title
The Formation of Marijuana Risk Perception in a Population of Substance Abusing Patients
Authors
Samuel T. Wilkinson
Gerrit I. van Schalkwyk
Larry Davidson
Deepak C. D’Souza
Publication date
01-03-2016
Publisher
Springer US
Published in
Psychiatric Quarterly / Issue 1/2016
Print ISSN: 0033-2720
Electronic ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-015-9369-z

Other articles of this Issue 1/2016

Psychiatric Quarterly 1/2016 Go to the issue